Thermo Fisher Scientific Sees Unusual Put Activity as Bears Target Near-Term Downside
By TrendSpider Editor
TMO market update based on latest unusual_options data.
Thermo Fisher Scientific Sees Unusual Put Activity as Bears Target Near-Term Downside
Thermo Fisher Scientific (TMO) is drawing attention from options traders today, with three unusual put contracts totaling $1,059,865 in combined premium flagged on the session. Shares are essentially flat, down just 0.23% to $586.70, trading in the middle of a wide 52-week range that stretches from $435.27 to $643.99, leaving meaningful room for movement in either direction.Key Drivers of the TMO Stock Move
- Main Catalyst: Three unusual put contracts hit the tape today, all carrying elevated open interest percentages. The largest by premium is a PUT at the $590 strike expiring January 15, 2027, with 250 contracts trading at a $1,001,250 premium and an OI ratio of 260%. Two shorter-dated puts also appeared: a PUT at $580 expiring August 21, 2026 with 131 contracts and $32,095 in premium (OI ratio of 374%), and a PUT at $587.50 also expiring August 21, 2026 with just 39 contracts but a striking OI ratio of 3,900% and $26,520 in premium.
- Bull Case: TMO shares remain well above the 52-week low of $435.27, and the $590 strike January put is only slightly in the money relative to the current price of $586.70. The positioning could represent hedging activity rather than an outright directional bet against the stock, and the total premium of roughly $1.06 million is not an outsized figure for a large-cap name like Thermo Fisher.
- Bear Case: All three contracts are puts, and the concentration of activity on the bearish side with zero calls flagged is a notable signal. The $587.50 put expiring this Friday carries an OI ratio of 3,900%, meaning volume today dwarfs existing open interest by nearly 39 times. The near-term expiration on two of the three contracts suggests traders are positioning for a potential move lower within days, not months.
TMO Unusual Options Activity
Three unusual put contracts were flagged today with no calls appearing in the unusual flow, pointing to a distinctly one-sided bearish setup:- PUT $580 | Expiry: August 21, 2026 | Volume: 131 | OI Ratio: 374% | Out of the money | Premium: $32,095
- PUT $590 | Expiry: January 15, 2027 | Volume: 250 | OI Ratio: 260% | In the money | Premium: $1,001,250
- PUT $587.50 | Expiry: August 21, 2026 | Volume: 39 | OI Ratio: 3,900% | In the money | Premium: $26,520
TMO Seasonality
Mid-to-late August has historically been a mixed period for large-cap life science and laboratory equipment names, as institutional investors reassess portfolio positioning ahead of the fall earnings season. The short-dated put activity expiring this week aligns with a period when summer liquidity can amplify price moves on relatively modest volume.TMO Relative Performance
TMO's 0.23% decline today is a muted move relative to the broader market, though the unusual options flow suggests some participants expect that calm to be short-lived. With the stock at $586.70, it sits roughly 91% above its 52-week low of $435.27 but still about 9% below the 52-week high of $643.99, leaving room on both sides for a sustained directional move depending on how the near-term catalysts develop.More on TMO
- Thermo Fisher Scientific Tops Q2 2026 Estimates on EPS and Revenue, But Shares Slide 2.56% in Premarket Trading
- Thermo Fisher Scientific Tops Q2 2026 Earnings and Revenue Estimates as EPS Surges 12.5%
- Thermo Fisher Scientific Sees $1.6M Bullish Call Sweep as Stock Holds Near Midpoint of 52-Week Range
- Thermo Fisher Scientific Sees $4M in Bullish Call Activity as Stock Climbs Nearly 3%
- Thermo Fisher Scientific Sees Unusual Put Activity and a $3.5M Call Bet as Shares Slide 2.38%
Latest Market News
- Procter & Gamble Slides 1.05% as Stock Hovers Near 52-Week Low
- ARM Holdings Sees $3.6M in Unusual Call Activity as Stock Trades Near Midpoint of 52-Week Range
- Microsoft Stock Flags Bearish Signal as $1.99M Put Sweep Targets $480 Strike Into January 2027
- Merck Scores Morgan Stanley Upgrade to Buy With $179 Target as RBC Cuts to Hold
- AbbVie Stock Pulls Back 1.15% But Holds Near 52-Week High of $267.47
- Coca-Cola Stock Clears 52-Week High at $91.20, Signaling Fresh Bullish Momentum